Onyx Pharmaceuticals Company Profile (NASDAQ:ONXX)

About Onyx Pharmaceuticals (NASDAQ:ONXX)

Onyx Pharmaceuticals logoOnyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company. The Company is developing therapies that target the molecular mechanisms that cause cancer. The Company has built two franchise platforms: one in kinase inhibition and one in proteasome inhibition. In its kinase inhibitor franchise, its product, Nexavar (sorafenib) tablets is approved for unresectable liver cancer and advanced kidney cancer. unresectable liver cancer and advanced kidney cancer. With its development and marketing partner Bayer HealthCare Pharmaceuticals Inc., or Bayer, the Company shares equally in the profits and losses of Nexavar worldwide except Japan. A kinase inhibitor, regorafenib, is an investigational agent that has already demonstrated positive Phase 3 survival data in metastatic colorectal cancer, and is being evaluated in a Phase 3 study in gastrointestinal stromal tumors (GIST).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:ONXX
  • CUSIP: 68339910
  • Web: N/A
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 226.73
  • P/E Growth: N/A
  • Dividend Yield: 1.0%
Frequently Asked Questions for Onyx Pharmaceuticals (NASDAQ:ONXX)

What is Onyx Pharmaceuticals' stock symbol?

Onyx Pharmaceuticals trades on the NASDAQ under the ticker symbol "ONXX."

Who are some of Onyx Pharmaceuticals' key competitors?

How do I buy Onyx Pharmaceuticals stock?

Shares of Onyx Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Onyx Pharmaceuticals' stock price today?

One share of Onyx Pharmaceuticals stock can currently be purchased for approximately $124.70.

MarketBeat Community Rating for Onyx Pharmaceuticals (NASDAQ ONXX)
Community Ranking:  3.0 out of 5 (  )
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  159 (Vote Underperform)
Total Votes:  402
MarketBeat's community ratings are surveys of what our community members think about Onyx Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Onyx Pharmaceuticals (NASDAQ:ONXX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Onyx Pharmaceuticals (NASDAQ:ONXX)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for Onyx Pharmaceuticals (NASDAQ:ONXX)
Earnings by Quarter for Onyx Pharmaceuticals (NASDAQ:ONXX)
Earnings History by Quarter for Onyx Pharmaceuticals (NASDAQ ONXX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2013Q2 2013($0.42)($0.40)$151.73 million$153.00 millionViewN/AView Earnings Details
5/7/2013Q1 2013($0.47)($0.19)$134.36 million$145.50 millionViewN/AView Earnings Details
2/21/2013Q4 2012($0.76)($0.36)$113.17 million$127.90 millionViewN/AView Earnings Details
11/1/2012Q312($0.95)($0.79)$80.02 million$89.51 millionViewN/AView Earnings Details
8/1/2012($0.69)($0.68)ViewN/AView Earnings Details
5/2/2012($0.60)($0.68)ViewN/AView Earnings Details
2/22/2012$1.61$1.50ViewN/AView Earnings Details
11/2/2011($0.27)($0.31)ViewN/AView Earnings Details
8/3/2011($0.17)($0.43)ViewN/AView Earnings Details
5/4/2011($0.13)($0.23)ViewN/AView Earnings Details
2/23/2011($0.02)($0.28)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Onyx Pharmaceuticals (NASDAQ:ONXX)
Current Year EPS Consensus Estimate: $-1.53 EPS
Next Year EPS Consensus Estimate: $0.55 EPS


Dividend History for Onyx Pharmaceuticals (NASDAQ:ONXX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Onyx Pharmaceuticals (NASDAQ:ONXX)
Insider Trades by Quarter for Onyx Pharmaceuticals (NASDAQ:ONXX)
Insider Trades by Quarter for Onyx Pharmaceuticals (NASDAQ:ONXX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2013Helen TorleyEVPSell9,311$126.89$1,181,472.79View SEC Filing  
8/8/2013Matthew FustCFOSell2,492$128.21$319,499.32View SEC Filing  
8/7/2013Suzanne ShemaEVPSell4,052$131.86$534,296.72View SEC Filing  
8/6/2013Kaye Foster-CheekSVPSell8,878$132.81$1,179,087.18View SEC Filing  
7/30/2013Corinne H NevinnyDirectorSell1,500$131.26$196,890.00View SEC Filing  
7/26/2013Lopez Antonio J GrilloDirectorSell2,000$130.50$261,000.00View SEC Filing  
7/26/2013Matthew K FustCFOSell6,043$130.50$788,611.50View SEC Filing  
7/8/2013Suzanne M ShemaEVPSell4,052$135.76$550,099.52View SEC Filing  
7/2/2013Matthew K FustCFOSell1,551$132.80$205,972.80View SEC Filing  
7/1/2013Juergen LasowskiEVPSell25,375$132.63$3,365,486.25View SEC Filing  
7/1/2013Julianna R WoodVPSell2,304$132.63$305,579.52View SEC Filing  
7/1/2013Paul GoddardDirectorSell6,000$132.21$793,260.00View SEC Filing  
6/19/2013Corinne H NevinnyDirectorSell1,000$88.25$88,250.00View SEC Filing  
6/10/2013Julianna R WoodVPSell2,306$92.30$212,843.80View SEC Filing  
6/7/2013Suzanne M ShemaEVPSell4,052$91.23$369,663.96View SEC Filing  
6/5/2013N Anthony ColesCEOSell6,562$90.00$590,580.00View SEC Filing  
5/14/2013Juergen LasowskiEVPSell4,182$96.60$403,981.20View SEC Filing  
5/13/2013Helen TorleyEVPSell8,250$98.13$809,572.50View SEC Filing  
5/13/2013Matthew K FustCFOSell10,269$98.22$1,008,621.18View SEC Filing  
4/11/2013Lopez Antonio J GrilloDirectorSell43,164$96.73$4,175,253.72View SEC Filing  
4/10/2013Julianna R WoodVPSell9,948$95.00$945,060.00View SEC Filing  
4/10/2013Paul GoddardDirectorSell2,000$95.00$190,000.00View SEC Filing  
3/11/2013Julianna R WoodVPSell3,331$85.65$285,300.15View SEC Filing  
3/11/2013Magnus LundbergDirectorSell5,000$88.00$440,000.00View SEC Filing  
10/5/2012Juergen LasowskiEVPSell5,902$90.00$531,180.00View SEC Filing  
10/4/2012Helen TorleyEVPSell2,314$86.51$200,184.14View SEC Filing  
10/2/2012Kaye I Foster-CheekSVPSell2,015$85.08$171,436.20View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Onyx Pharmaceuticals (NASDAQ:ONXX)
Latest Headlines for Onyx Pharmaceuticals (NASDAQ:ONXX)
bizjournals.com logoGoogle unit stakes biotech claim with lease of entire Onyx campus
www.bizjournals.com - February 18 at 9:31 AM
cnbc.com logoFormer Teva CEO's new gig at Ovid Therapeutics
www.cnbc.com - April 16 at 6:10 AM



Onyx Pharmaceuticals (ONXX) Chart for Saturday, July, 29, 2017

This page was last updated on 7/29/2017 by MarketBeat.com Staff